Medicine information CUPRIPEN 250mg capsules
- Product code:
- W61063002
- Quantity:
- 30
- Indicated for:
- Wilson disease
- Route of administration:
- oral
- Substance:
- penicillamine (chelating agent)
- ATC
- M01CC01 — Musculo-skeletal system | Specific antirheumatic agents | Penicillamine and similar agents
Penicillamine is a medication used for the treatment of Wilson's disease, severe rheumatoid arthritis, and heavy metal poisoning, such as lead. It works by binding heavy metals or reducing inflammation in the case of arthritis.
The medication is taken orally, usually in the form of capsules or tablets, and should be used as directed by your doctor. Regular blood tests are important to monitor kidney function and heavy metal levels.
Side effects may include nausea, skin rashes, weight loss, or, in rare cases, severe reactions such as kidney or bone marrow impairment.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of penicillamine.
The medication is taken orally, usually in the form of capsules or tablets, and should be used as directed by your doctor. Regular blood tests are important to monitor kidney function and heavy metal levels.
Side effects may include nausea, skin rashes, weight loss, or, in rare cases, severe reactions such as kidney or bone marrow impairment.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of penicillamine.
General data about CUPRIPEN 250mg
- Substance:
- penicillamine
- Date of latest medicines list:
- 01-10-2026
- Product code:
- W61063002
- Strength:
- 250mg
- Pharmaceutical form:
- capsules
- Quantity:
- 30
- Product type:
- Generic medicine
- Price:
- 113.64 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for penicillamine
Official documents
The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.
- Added to database:
- 09/09/2009
- Source record updated:
- 07/11/2025